Latest filing published 19 Sept 2023 for Biora Therapeutics, INC..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
This profile gathers the share dealings of Athyrium Opportunities III Co-Invest 1 LP in Biora Therapeutics, Inc. In total, 3 filings cover trades dated from 9 November 2022 to 18 September 2023.
Purchases make up the whole of the open-market record (1 purchase). The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 1 share grant.
The record was last updated on 19 September 2023 with a share grant in Biora Therapeutics, Inc. The last purchase on record was published on 14 November 2022, which is 1,441 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations